PolyNovo (ASX:PNV) CEO Paul Brennan podcast

A global medical device company, PolyNovo (ASX:PNV) is focused on delivering improved patient outcomes through the use of innovative polymer technology.

CEO Paul Brennan discusses their growth opportunities for this wound technology including their FDA approval in the USA and anticipated listing on the Australian Register of Therapeutic Goods (ARTG) in the second quarter of 2018.